SOLACI Board 2023-2025

President: Dr. Mario Araya (CHI)

  • Interventional Cardiologist
  • Former Director of SOLACI Sessions
  • Member of the Steering Committee of the SOLACI-LATAM Bif Registry
  • President for 6 years of the Department of Hemodynamics of the Chilean Society of Cardiology (SOCHICAR)

Vice President: Dr. Ricardo Costa (BRA)

  • Interventional Cardiologist at the Dante Pazzanese Institute of Cardiology
  • Post graduation at Columbia University, New York, USA
  • PhD from the University of São Paulo
  • Post Doctorate from the Dante Pazzanese Institute of Cardiology
  • President of the Brazilian Society of Hemodynamics and Interventional Cardiology (SBHCI), 2022 / 2023

Treasurer: Dr. Omar Santaera (ARG)

  • Interventional Cardiologist
  • Former President of the Argentine College of Interventional Cardioangiologists (CACI)
  • Head of Interventional Cardiology Service – Provincial Private Clinic – Merlo – Buenos Aires Argentina

Secretary: Dr. Pedro Hidalgo (VEN)

  • Interventional cardiologist trained at the Dante Pazzanese Institute
  • Director of the Cath Lab. Amado Polyclinic. Maracaibo Venezuela
  • Former president of SOVECI

Vocal
Andean Region: Dra. Bertha Gonzáles (Peru), Dr. Carlos Uribe, (Colombia)
Central America and the Caribbean: Dr. Juan José Flores Molina, El Salvador
Southern Region: Dr. Luis Urna (Bolivia), Dr. Rogério Sarmento Leite (Brazil)
Alternate Vocals
Dr. Federico Borges (Venezuela)
Dr. Jorge Cortes Lawrenz (Mexico)
Previous article
Next article

More articles by this author

Registration Open for Module 2 of the 2026 Annual Course: Multislice CT and Cardiovascular Magnetic Resonance Imaging

The Latin American Society of Interventional Cardiology (SOLACI) and the Argentine College of Interventional Cardioangiologists (CACI) announce the opening of registration for Module 2...

EuroPCR 2026 | Is localized anticoagulation the next step for coronary stents?

The DESyne BDS Plus stent was developed as a thin-strut, bioabsorbable polymer drug-eluting stent that combines sirolimus release with two anticoagulant agents (rivaroxaban and...

Esta es una entrada en ingles

demo en ingles

test eng

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...